Tech Company Financing Transactions

Ribon Therapeutics Funding Round

Ribon Therapeutics closed a $65 million venture capital round on 7/15/2021. Investors included Deerfield Capital, U.S. Venture Partners and AbbVie Biotech Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

35 Cambridgepark Dr.
Cambridge, MA 02140
USA

Phone

(617) 914-8700

Website

www.ribontx.com

Email Address

[email protected]

Overview

Ribon is pioneering the development of first-in-class therapeutics targeting enzyme families that are activated under cellular stress conditions. We explore novel areas of disease biology and use our expertise in drug discovery to develop new and effective treatments for patients with high unmet need.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Victoria Richon

        

Chief Financial Officer

Paul Brannelly

        

Chief Medical Officer

Sudha Parasuraman

        

Vice President

Heike Keilhack

        

Vice President

Kevin Kuntz

        

VP - Bus. Development

Edward Stewart

        

Browse more venture capital transactions:

Prev: 7/15/2021: Kriya Therapeutics venture capital transaction
Next: 7/15/2021: Apty venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary